Merck, Pfizer settle patent dispute over pneumococcal vaccine Ruchika Sharma28 Sept 2021 12:00 PM ISTNew Delhi: Merck Sharp & Dohme Corp and Pfizer's Wyeth LLC subsidiary have resolved a patent dispute over their competing vaccines for preventing...
Merck gives Rs 1.7 crore fund to IIT Bombay for COVID research Ruchika Sharma26 Aug 2021 12:00 PM ISTMumbai: Merck, a science and technology company, today announced a donation of INR 1.7 crore over two years to the Indian Institute of Technology...
Merck HIF-2α Inhibitor Welireg gets USFDA approval to treat tumors Ruchika Sharma16 Aug 2021 10:00 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the U.S. Food and Drug Administration (FDA) has...
Merck KGaA raises outlook after forecast-beating Q2 profit Ruchika Sharma8 Aug 2021 9:15 AM ISTBerlin: Merck KGaA raised its outlook after posting forecast-beating second quarter profits on Thursday, boosted by demand for its lab gear and...
Merck gets USFDA nod for Pneumococcal 15-valent Conjugate Vaccine Ruchika Sharma18 July 2021 10:30 AM ISTKenilworth: Merck known as MSD outside the United States and Canada, has recently announced the U.S. Food and Drug Administration (USFDA) approved...
Sanofi-Merck six-in-one pediatric combination vaccine Vaxelis available in US Ruchika Sharma3 Jun 2021 11:00 AM ISTBridgewater: Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B...
Merck announces Rs 17.85 crores caring aid to India for COVID relief Ruchika Sharma3 Jun 2021 10:00 AM ISTMumbai: Merck has recently announced its support to India in combating the recent surge in Covid-19 cases.With the country grappling with...
Himachal drugmaker agrees to destroy infringed stock of Merck Diabetes Drug Sitagliptin Medical Dialogues Team7 April 2021 6:42 PM ISTNew Delhi: In a relief to Merck, Hariom Pharmachem has agreed to destroy the stock of infringed products of Merck's popular diabetes drug Sitagliptin,...
Gilead Sciences, Merck collaborate to develop, commercialize Lenacapavir, Islatravir combo for HIV Ruchika Sharma17 March 2021 1:04 PM ISTFoster City & Kenilworth: Gilead Sciences, Inc. and Merck, known as MSD outside the United States and Canada, have recently announced that they...
Merck phase 1 trial for Islatravir subdermal implant to prevent HIV-1 Infection shows positive results Ruchika Sharma10 March 2021 11:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced results from a Phase 1 study evaluating the safety,...
Merck to buy Pandion Therapeutics for USD 1.85 billion Ruchika Sharma28 Feb 2021 9:45 AM ISTKenilworth & Watertown: Merck, known as MSD outside the United States and Canada, and Pandion Therapeutics, Inc. have recently announced that the...
Merck halts 2 Covid-19 vaccines development due to weak immune response MD Bureau26 Jan 2021 2:34 PM ISTWashington: US pharmaceutical giant Merck & Co announced that it is discontinuing development of its Covid-19 vaccine candidates -- V590 and...
